These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36201240)
21. Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Mokrysz C; Freeman TP; Korkki S; Griffiths K; Curran HV Transl Psychiatry; 2016 Nov; 6(11):e961. PubMed ID: 27898071 [TBL] [Abstract][Full Text] [Related]
22. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500 [TBL] [Abstract][Full Text] [Related]
23. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome. Abi-Jaoude E; Bhikram T; Parveen F; Levenbach J; Lafreniere-Roula M; Sandor P Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329 [No Abstract] [Full Text] [Related]
24. Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers. Wesnes KA; Annas P; Edgar CJ; Deeprose C; Karlsten R; Philipp A; Kalliomäki J; Segerdahl M J Psychopharmacol; 2010 Nov; 24(11):1659-69. PubMed ID: 19525335 [TBL] [Abstract][Full Text] [Related]
25. Enhancing effects of acute exposure to cannabis smoke on working memory performance. Blaes SL; Orsini CA; Holik HM; Stubbs TD; Ferguson SN; Heshmati SC; Bruner MM; Wall SC; Febo M; Bruijnzeel AW; Bizon JL; Setlow B Neurobiol Learn Mem; 2019 Jan; 157():151-162. PubMed ID: 30521850 [TBL] [Abstract][Full Text] [Related]
26. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans. Cortes-Briones JA; Cahill JD; Skosnik PD; Mathalon DH; Williams A; Sewell RA; Roach BJ; Ford JM; Ranganathan M; D'Souza DC Biol Psychiatry; 2015 Dec; 78(11):805-13. PubMed ID: 25913109 [TBL] [Abstract][Full Text] [Related]
27. Evaluating a new verbal working memory-balance program: a double-blind, randomized controlled trial study on Iranian children with dyslexia. Ramezani M; Behzadipour S; Pourghayoomi E; Joghataei MT; Shirazi E; Fawcett AJ BMC Neurosci; 2021 Sep; 22(1):55. PubMed ID: 34525977 [TBL] [Abstract][Full Text] [Related]
28. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107 [TBL] [Abstract][Full Text] [Related]
29. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290 [TBL] [Abstract][Full Text] [Related]
30. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol. Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N; BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349 [TBL] [Abstract][Full Text] [Related]
34. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse. Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231 [TBL] [Abstract][Full Text] [Related]
35. Analgesic and antihyperalgesic effects of nabilone on experimental heat pain. Redmond WJ; Goffaux P; Potvin S; Marchand S Curr Med Res Opin; 2008 Apr; 24(4):1017-24. PubMed ID: 18302810 [TBL] [Abstract][Full Text] [Related]
37. Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis. Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; Kambeitz J; Malhi S; Giampietro V; Williams S; Brammer M; Rubia K; Collier DA; McGuire PK Eur Neuropsychopharmacol; 2015 Jan; 25(1):26-37. PubMed ID: 25532865 [TBL] [Abstract][Full Text] [Related]
38. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. van Amsterdam J; Brunt T; van den Brink W J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398 [TBL] [Abstract][Full Text] [Related]
39. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793 [TBL] [Abstract][Full Text] [Related]
40. Cannabis-based medicines for chronic neuropathic pain in adults. Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]